Patrick Frost, PhD

Patrick Frost, PhD

May 05, 2016

Group 6 Copy 55
0
Please wait...

About This Project

BBRI and Los Angeles VA Medical Center

Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

Blast off!

Browse Other Projects on Experiment

Related Projects

Are cryptic characteristics preventing the protection of two similar Sphingidae moths?

This project is aimed at understanding the morphological differences between two species of Sphingidae...

Biological control of the mosquito Aedes aegypti

The mosquito A. aegypti is the main vector for dengue and zika viruses. This mosquito has developed resistance...

Probiotics for plants? Fighting insects by boosting corn immune systems

Beneficial soil microorganisms can boost the plant immune system. We want to know if farming practices that...

Backer Badge Funded